Kyverna Therapeutics Market Sentiment

Kyverna Therapeutics Inc

KYTXNASDAQ

Trade with Public

$8.84

0.607.28%

가까이에: Aug 25, 5:00 PM EST

$8.68

-0.16-1.8%

시간외: 6:05 PM EST

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Kyverna Therapeutics Market Sentiment

Market sentiment signals for Kyverna Therapeutics (KYTX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Overweight

Short Interest▼ 15.8% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Overweight

7 analysts

Options Flow (P/C)

0.00

More calls — Bullish

641 calls · 1 puts

Avg Consensus PT

$22

+149.6%

Highest Price Target

$33

+280.1%

Wells Fargo

Lowest Price Target

-42.4%

HC Wainwright & Co.

Short Interest

15.8%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Jun 3, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+188.0%	$25 → $25	Maintained	Buy
May 15, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+188.0%	$20 → $25	Maintained	Buy
May 13, 2026	JP Morgan	Brian Cheng—	+234.1%	$30 → $29	Maintained	Overweight
Apr 23, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+130.4%	$20 → $20	Maintained	Buy
Dec 16, 2025	Wells Fargo	Derek Archila—	+280.1%	$31 → $33	Maintained	Overweight
Dec 4, 2025	Morgan Stanley	Michael Ulz—	+188.0%	$20 → $25	Maintained	Overweight
Oct 30, 2025	Wells Fargo	Derek Archila—	+257.1%	$27 → $31	Maintained	Overweight
Oct 27, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	+130.4%	$10 → $20	Maintained	Buy
Oct 8, 2025	Wells Fargo	Derek Archila—	+211.0%	$24 → $27	Maintained	Overweight
Aug 29, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	+15.2%	$5 → $10	Maintained	Buy
Aug 20, 2025	William Blair	Sami Corwin—	—	—	Initiate	Outperform
May 27, 2025	HC Wainwright & Co.	Mitchell Kapoor—	-42.4%	$4 → $5	Upgrade	Neutral→Buy
Apr 3, 2025	HC Wainwright & Co.	Mitchell Kapoor—	-53.9%	$6 → $4	Maintained	Neutral
Apr 1, 2025	Morgan Stanley	Michael Ulz—	+130.4%	$40 → $20	Maintained	Overweight
Nov 20, 2024	HC Wainwright & Co.	Mitchell Kapoor—	-30.9%	$7 → $6	Maintained	Neutral
Nov 15, 2024	Wells Fargo	Derek Archila—	+176.5%	$44 → $24	Maintained	Overweight
Oct 10, 2024	UBS	Trung Huynh—	+49.7%	$13	Initiate	Buy
Sep 19, 2024	HC Wainwright & Co.	Mitchell Kapoor—	-19.4%	$7 → $7	Maintained	Neutral
Aug 15, 2024	HC Wainwright & Co.	Mitchell Kapoor—	-19.4%	$8 → $7	Maintained	Neutral
Jul 31, 2024	JP Morgan	Brian Cheng—	+280.1%	$39 → $33	Maintained	Overweight
Jul 16, 2024	HC Wainwright & Co.	Mitchell Kapoor—	-7.8%	$8 → $8	Maintained	Neutral
Jul 3, 2024	HC Wainwright & Co.	Mitchell Kapoor—	-7.8%	$8	Initiate	Neutral
Mar 4, 2024	JP Morgan	Brian Cheng—	+349.2%	$39	Initiate	Overweight
Mar 4, 2024	Morgan Stanley	Michael Ulz—	+360.8%	$40	Initiate	Overweight

More with Benzinga EdgeGet Access

Kyverna Therapeutics Inc

Kyverna Therapeutics Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

People Also Watch

뉴스

파트너 / 기고자

벤징가 글로벌

Bulls vs Bears

People Also Watch